Imunon, INC Form 4 insider transactions

Michael H. Tardugno, Executive Chairman of Imunon, Inc., acquired stock options exercisable for 12,500 shares of common stock on March 15, 2024.

Director Frederick J. Fritz acquired stock options for 3,500 shares of Imunon, Inc. at an exercise price of $0.86 on March 15, 2024.

Donald P. Braun, a director of Imunon, Inc., acquired options to purchase 3,500 shares of Imunon common stock at an exercise price of $0.86 on March 15, 2024.

Christine A. Pellizzari, a director of Imunon, Inc., acquired stock options exercisable for 4,500 shares of common stock at a price of $0.86 on March 15, 2024.

Director Stacy Lindborg reports the acquisition of stock options in Imunon, Inc.

Director James E. Dentzer acquired stock options in Imunon, Inc. on March 15, 2024.